The number of neurons and glia in the albino mouse parabigeminal nucleus remains constant between 6 and 31 months of age. The presence of a small number of mitotic and pyknotic cells in the parabigeminal nucleus indicates a slow turnover of the glial population throughout life. Examination of the superior colliculus showed that degenerating neurons were present from 6 months of age and neurons appeared to be much more sparsely scattered in the superficial layers of aged mice than in young adults. The stability of the neuron number in the parabigeminal nucleus may be due to the reciprocal innervation of neurons of the superior colliculi and parabigeminal nuclei protecting each other from transneuronal degeneration which might otherwise occur as a consequence of loss of retinal ganglion cells. Alternatively, since each neuron in the parabigeminal nucleus probably synapses with many tectal neurons, the loss of only some of its target neurons would probably not lead to transneuronal degeneration.

Keywords:
Neurons, Glia, Parabigeminal nucleus
This content is only available via PDF.
© 1989 S. Karger AG, Basel
1989
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.